Atlas Trials

An Open-Label Study of the Safety of Interferon Gamma-1b in Patients With IPF

Clinical trial NCT00076635 · TERMINATED

Trial details

NCT number
NCT00076635
Sponsor
InterMune
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Idiopathic Pulmonary FibrosisPulmonary FibrosisLung Disease
Start date
2003-11-01
Enrollment
91

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.